home.aspx
 
EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.

Amira Pharmaceuticals

SHARESHARESHARE
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.
SHARESHARESHARE

RELATED NEWS


Compared to the previous year, the total income of non-tariff and senior executives in the chemical-pharmaceutical industry in 2018 increased by 4.4 percent. This is the result of the current income survey of the Association of Hired Academics (VAA).The increase was 0.8 percentage points stronger than in the previous year. The reason for this is the growth in variable remuneration, which grew by 3.2 percent in 2017 to 5.9 percent last year. "For the academics and executives of the chemical ...

READ MORE

Corporate lobbyists collected almost $1 million for the Democratic Congressional Campaign Committee (DCCC) during the first quarter of 2019, according to an analysis by MapLight and Sludge. The amounts have been rising gradually since the first of the year, with lobbyists bundling almost $515,000for the committee in March—the month that the DCCC began drawing criticism from progressives for banning its political vendors from working for candidates who plan to challenge incumbent Democrats....

READ MORE

Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the drugs....

READ MORE

The World Health Organization (WHO) has launched a pilot programme for insulin prequalification to boost access to diabetes treatment. Under the two-year programme, primarily meant for low and middle-income countries, WHO will assess insulin developed by manufacturers for quality, safety, efficacy and affordability. It is in line with the organisation’s measures to address rising diabetes burden. Discovered nearly ten decades ago, insulin is required by patients with type 1 or type 2 diabe...

READ MORE

The modular components provide scientists with excellent process control, and the ability to choose from a range of particle diameters between 10 and 50 µm on a single piece of hardware. PLGA, or poly(lactic-co-glycolic acid), is a copolymer commonly used for drug microencapsulation. Precise manipulation of particle size, shape and architecture is extremely important to the efficacy of the candidate drug....

READ MORE

MADRID, Spain/TOKYO, Japan I December 22, 2016 I PharmaMar (MSE: PHM) has announced today the signing of an exclusive license, development and commercialization agreement with Chugai Pharmaceutical Co. Ltd. (Tokyo: 4519) for its third marine-derived anticancer drug PM1183 (lurbinectedin) in Japan. Under the terms of this agreement, PharmaMar will receive an upfront payment of €30 million, along with double-digit tiered royalties, and will also be eligible for receiving payments in line with the ...
PIPELINEREVIEW.COM
READ MORE

EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.